| 前收市價 | 4.9300 |
| 開市 | 4.9900 |
| 買盤 | 4.9700 x 200 |
| 賣出價 | 5.0300 x 300 |
| 今日波幅 | 4.9200 - 5.1100 |
| 52 週波幅 | 1.5200 - 8.1100 |
| 成交量 | |
| 平均成交量 | 121,655 |
| 市值 | 99.664M |
| Beta 值 (5 年，每月) | 0.80 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.1700 |
| 業績公佈日 | 2024年8月06日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 7.83 |
ZacksJourney Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA
Journey Medical (DERM) stock rises as the FDA accepts its regulatory filing for review seeking approval for DFD-29 to treat inflammatory lesions and erythema of rosacea in adults.
ZacksJourney Medical (DERM) to Report Q4 Earnings: What's in the Cards?
When Journey Medical (DERM) reports fourth-quarter 2023 results, investors will likely focus on the top and bottom-line numbers.
ZacksNovo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
Novo Nordisk (NVO) will acquire Catalent's three manufacturing sites from Novo Holdings to expand its manufacturing capacity.
